HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A pilot open-label study of the efficacy of subanesthetic isomeric S(+)-ketamine in refractory CRPS patients.

AbstractOBJECTIVE:
Complex regional pain syndrome (CRPS) is a severe neuropathic pain state that is often disproportionate to the initial trauma. Associated features are autonomic dysregulation, swelling, motor dysfunction, and trophic changes to varying degrees. Despite a multitude of treatment modalities, a subgroup of CRPS patients remain refractory to all standard therapies. In these patients, the disease may spread extraterritorially, which results in severe disability. A critical involvement of N-methyl-D-aspartate receptors (NMDARs) has been demonstrated both clinically and by animal experimentation. NMDA antagonists may be effective in many neuropathic pain states. In long-standing, generalized CRPS, we investigated the effects of S(+)-ketamine on pain relief and somatosensory features, assessed by quantitative sensory testing (QST).
METHODS:
Four refractory CRPS patients received continous S(+)-ketamine-infusions, gradually titrated (50 mg/day-500 mg/day) over a 10-day period. Pain intensities (average, peak, and least pain) and side effects were rated on visual analogue scales, during a 4-day baseline, over 10 treatment days, and 2 days following treatment. QST (thermo-, mechanical detection, and pain thresholds) was analyzed at baseline and following treatment.
RESULTS:
Subanesthetic S(+)-ketamine showed no reduction of pain and effected no change in thermo- and mechanical detection or pain thresholds. This procedure caused no relevant side effects. The lack of therapeutic response in the first four patients led to termination of this pilot study.
CONCLUSION:
S(+)-ketamine can be gradually titrated to large doses (500 mg/day) without clinically relevant side effects. There was no pain relief or change in QST measurements in this series of long-standing severe CRPS patients.
AuthorsRalph-Thomas Kiefer, Peter Rohr, Annette Ploppa, Boris Nohé, Hans-Jürgen Dieterich, John Grothusen, Karl-Heinz Altemeyer, Klaus Unertl, Robert J Schwartzman
JournalPain medicine (Malden, Mass.) (Pain Med) 2008 Jan-Feb Vol. 9 Issue 1 Pg. 44-54 ISSN: 1526-2375 [Print] England
PMID18254766 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Anesthetics, Dissociative
  • Ketamine
Topics
  • Adolescent
  • Adult
  • Anesthetics, Dissociative (adverse effects, chemistry, therapeutic use)
  • Complex Regional Pain Syndromes (drug therapy)
  • Drug Resistance
  • Female
  • Humans
  • Ketamine (adverse effects, chemistry, therapeutic use)
  • Male
  • Mechanoreceptors (drug effects)
  • Pain Measurement
  • Pain Threshold (drug effects)
  • Pilot Projects
  • Prospective Studies
  • Sensory Thresholds (drug effects)
  • Stereoisomerism
  • Thermosensing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: